pubrio
Embecta logo

Embecta

Public
+1
embecta.com
Medical Devices2,000+ employeesFounded 2022🇺🇸 United States

At embecta (formerly part of BD), we are singularly focused on improving the lives of people living with diabetes. With a 100-year legacy of developing and providing solutions to the diabetes community, today, we are a global medical technology company and leader in insulin delivery devices. More than 30 million people in over 100 countries rely on our pen needle and syringe products every day.  BD is the manufacturer of the advertised products.   Privacy Policy: https://www.embecta.com/en-us/about/policies/privacy-policy-statement

Founded
2022
Employees
2,000+
Industry
Medical Devices
Company type
Public Company
Stock
nasdaq: EMBC
Headquarters
🇺🇸Parsippany-Troy Hills, New Jersey, United States (+1)
Specialties
Medical DevicesPharmaceuticalsHealthcare
2 / 14
Active markets
China · Mexico · Singapore
0
New markets
Low
Confidence
mostly early signals
-50%
Momentum
vs prior period
20 / 100
Expansion Score
Early
Stages5Exploring9Investing
6 signals · Last 90 days

Global expansion

Live
ChinaMexicoSingapore
Stages
ExploringInvestingLandingOperating
+11more marketsLocked
3 of 14 shown

Unlock the market timeline & signal feed

Activity pulse

7 signals in the last 90 days.

Last 90 days
Hiring
7↑ +33%
Hiring
Marketing & PR
0
No activity
Product & Tech
0
No activity
+2more categoriesLocked
3 of 5 shown

Market entry timeline

The order this company entered each market — oldest to newest

1
🇸🇬Singapore1st market entered · 2024Advancing
Exploring
11 signalsExploring stage
2
🇨🇳China2nd market entered · 2024Advancing
Exploring
26 signalsExploring stage
3
🇲🇽Mexico3rd market entered · 2025Advancing
Exploring
12 signalsExploring stage
+11more marketsLocked
3 of 14 shown
Current stageInvestingCommitting resources
Confidence37%Low
Tracking since2024first signal

Recent signals

Headcount scaling🇮🇪 Ireland6d ago

15 active postings

Hiring🇮🇪 Irelandlast mo.

PQS Operator

Sign up to see the full signal feed

Good to know

Frequently Asked Questions Regarding Embecta

Quick answers about Embecta's business, markets, and growth signals.

At embecta (formerly part of BD), we are singularly focused on improving the lives of people living with diabetes. With a 100-year legacy of developing and providing solutions to the diabetes community, today, we are a global medical technology company and leader in insulin delivery devices. More than 30 million people in over 100 countries rely on our pen needle and syringe products every day.  BD is the manufacturer of the advertised products.   Privacy Policy: https://www.embecta.com/en-us/about/policies/privacy-policy-statement

Start your journey today

Start with the platform — or start with a conversation

Use Pubrio on your own, or let our team help you with research, lead generation, or data integration.

Start Journey Image
pubrio

Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.​

© 2026 Pubrio. All rights reserved.